2016
DOI: 10.1126/science.aaf6659
|View full text |Cite
|
Sign up to set email alerts
|

Senescent intimal foam cells are deleterious at all stages of atherosclerosis

Abstract: Advanced atherosclerotic lesions contain senescent cells, but the role of these cells in atherogenesis remains unclear. Using transgenic and pharmacological approaches to eliminate senescent cells in atherosclerosis-prone low-density lipoprotein receptor–deficient (Ldlr−/−) mice, we show that these cells are detrimental throughout disease pathogenesis. We find that foamy macrophages with senescence markers accumulate in the subendothelial space at the onset of atherosclerosis, where they drive pathology by inc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

20
778
1
5

Year Published

2018
2018
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 893 publications
(855 citation statements)
references
References 30 publications
20
778
1
5
Order By: Relevance
“…This hypothesis is supported by studies demonstrating that accumulation of senescent cells is causal in driving aging‐associated pathologies. For example, the ablation of senescent cells using the INK‐ATTAC or the p16‐3MR technologies, pharmacologically targeting the Ink4a transcriptionally active promoter in senescent cells, extended lifespan and improved healthspan in mice (Baker et al., 2011, 2016; Childs et al., 2016). …”
Section: Discussionmentioning
confidence: 99%
“…This hypothesis is supported by studies demonstrating that accumulation of senescent cells is causal in driving aging‐associated pathologies. For example, the ablation of senescent cells using the INK‐ATTAC or the p16‐3MR technologies, pharmacologically targeting the Ink4a transcriptionally active promoter in senescent cells, extended lifespan and improved healthspan in mice (Baker et al., 2011, 2016; Childs et al., 2016). …”
Section: Discussionmentioning
confidence: 99%
“…This complex stress response induces a near permanent cell cycle arrest, adaptations to maintain survival, cellular remodeling, metabolic dysfunction, and disruption of surrounding tissue due to the secretion of toxic molecules (Childs et al, 2016). While many of these features have been described in AD brains and transgenic animal models throughout the literature (e.g., aberrant cell cycle activity, p16 INK4A co‐localization with NFTs (Arendt, Rodel, Gartner, & Holzer, 1996), decreased lamin B1, and heterochromatin relaxation (Frost, Bardai, & Feany, 2016); a role for cellular senescence in AD‐associated neurodegeneration has not been investigated.…”
Section: Introductionmentioning
confidence: 99%
“…This hypothesis is supported by recent studies demonstrating that the genetic clearance of SCs prolongs the lifespan of mice and delays the onset of several age‐related diseases and disorders in both progeroid and naturally aged mice (Baker et al., 2011, 2016). Therefore, the pharmacological clearance of SCs with a small molecule, a senolytic agent that can selectively kill SCs, is potentially a novel anti‐aging strategy and a new treatment for chemotherapy‐ and radiotherapy‐induced side effects (Baar et al., 2017; Chang et al., 2016; Childs et al., 2016; Demaria et al., 2017; Jeon et al., 2017; Ogrodnik et al., 2017; Pan et al., 2017; Schafer et al., 2017; Yosef et al., 2016; Zhu et al., 2015). …”
Section: Introductionmentioning
confidence: 99%